These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1909378)

  • 1. Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy.
    Oredipe OA; White SL; Grzegorzewski K; Gause BL; Cha JK; Miles VA; Olden K
    J Natl Cancer Inst; 1991 Aug; 83(16):1149-56. PubMed ID: 1909378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swainsonine stimulation of the proliferation and colony forming activity of murine bone marrow.
    White SL; Nagai T; Akiyama SK; Reeves EJ; Grzegorzewski K; Olden K
    Cancer Commun; 1991 Mar; 3(3):83-91. PubMed ID: 1900427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice primed with swainsonine are protected against doxorubicin-induced lethality.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1089-99. PubMed ID: 14682391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Oct; 3(10-11):1537-47. PubMed ID: 12946451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1037-48. PubMed ID: 14682385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.
    Klein JL; Roberts JD; George MD; Kurtzberg J; Breton P; Chermann JC; Olden K
    Br J Cancer; 1999 Apr; 80(1-2):87-95. PubMed ID: 10389983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swainsonine stimulates bone marrow cell proliferation and differentiation in different strains of inbred mice.
    Oredipe OA; Furbert-Harris PM; Green WR; White SL; Olden K; Laniyan I; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Pharmacol Res; 2003 Jan; 47(1):69-74. PubMed ID: 12526864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
    Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
    Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lysosomal alpha-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens.
    Dorling PR; Huxtable CR; Colegate SM
    Biochem J; 1980 Nov; 191(2):649-51. PubMed ID: 6786280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Clin Exp Metastasis; 1990; 8(1):89-102. PubMed ID: 2104578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
    Dennis JW; Koch K; Yousefi S; VanderElst I
    Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential importance of swainsonine in therapy for cancers and immunology.
    Olden K; Breton P; Grzegorzewski K; Yasuda Y; Gause BL; Oredipe OA; Newton SA; White SL
    Pharmacol Ther; 1991; 50(3):285-90. PubMed ID: 1754603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonoyloxy analogs of the anti-metastatic drug swainsonine. Activation in tumor cells by esterases.
    Dennis JW; White SL; Freer AM; Dime D
    Biochem Pharmacol; 1993 Oct; 46(8):1459-66. PubMed ID: 8240396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
    Dennis JW
    Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of macrophage tumoricidal activity, major histocompatibility complex class II antigen (Iak) expression, and interleukin-1 production by swainsonine.
    Grzegorzewski K; Newton SA; Akiyama SK; Sharrow S; Olden K; White SL
    Cancer Commun; 1989; 1(6):373-9. PubMed ID: 2484638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swainsonine: a new antineoplastic immunomodulator.
    Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K
    J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
    Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.